BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 12 Mar 2022)

Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling study
Dynamic modeling is commonly used to evaluate direct and indirect effects of interventions on infectious disease incidence. The risk of secondary outcomes (e.g., death) attributable to infection may depend on …
Authors: Allison Portnoy, Yuli Lily Hsieh, Kaja Abbas, Petra Klepac, Heather Santos, Logan Brenzel, Mark Jit and Matthew Ferrari
Citation: BMC Medicine 2022 20:113

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 12 Mar 2022)

WHO-led consensus statement on vaccine delivery costing: process, methods, and findings
Differences in definitions and methodological approaches have hindered comparison and synthesis of economic evaluation results across multiple health domains, including immunization. At the request of the World Health Organization’s (WHO) Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC), WHO convened an ad hoc Vaccine Delivery Costing Working Group, comprising experts from eight organizations working in immunization costing, to address a lack of standardization and gaps in definitions and methodological guidance. The aim of the Working Group was to develop a consensus statement harmonizing terminology and principles and to formulate recommendations for vaccine delivery costing for decision making. This paper discusses the process, findings of the review, and recommendations in the Consensus Statement.
Authors: Ann Levin, Laura Boonstoppel, Logan Brenzel, Ulla Griffiths, Raymond Hutubessy, Mark Jit, Vittal Mogasale, Sarah Pallas, Stephen Resch, Christian Suharlim and Karene Hoi Ting Yeung
Citation: BMC Medicine 2022 20:88
Content type: Guideline
Published on: 8 March 2022

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 12 Mar 2022)

A study of SARS-COV-2 outbreaks in US federal prisons: the linkage between staff, incarcerated populations, and community transmission
Since the novel coronavirus SARS-COV-2 was first identified to be circulating in the US on January 20, 2020, some of the worst outbreaks have occurred within state and federal prisons. The vulnerability of inc…
Authors: Sherry Towers, Danielle Wallace, Jason Walker, John M. Eason, Jake R. Nelson and Tony H. Grubesic
Citation: BMC Public Health 2022 22:482

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 12 Mar 2022)

Social responsibility perspective in public response to the COVID-19 pandemic: a grounded theory approach
Combating viral outbreaks extends beyond biomedical and clinical approaches; thus, public health prevention measures are equally important. Public engagement in preventive efforts can be viewed as the social r…
Authors: Lee Lan Low, Seng Fah Tong, Ju Ying Ang, Zalilah Abdullah, Maimunah A Hamid, Mikha Saragi Risman, Yun Teng Wong, Nurul Iman Jamalul-lail, Kalvina Chelladorai, Yui Ping Tan, Yea Lu Tay, Awatef Amer Nordin and Amar-Singh HSS
Citation: BMC Public Health 2022 22:469

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 12 Mar 2022)

COVID-19 vaccine perceptions in the initial phases of US vaccine roll-out: an observational study on reddit
Open online forums like Reddit provide an opportunity to quantitatively examine COVID-19 vaccine perceptions early in the vaccine timeline. We examine COVID-19 misinformation on Reddit following vaccine scient…
Authors: Navin Kumar, Isabel Corpus, Meher Hans, Nikhil Harle, Nan Yang, Curtis McDonald, Shinpei Nakamura Sakai, Kamila Janmohamed, Keyu Chen, Frederick L. Altice, Weiming Tang, Jason L. Schwartz, S. Mo Jones-Jang, Koustuv Saha, Shahan Ali Memon, Chris T. Bauch…
Citation: BMC Public Health 2022 22:446
Content type: Research
Published on: 7 March 2022

Epidemics
Volume 38 March 2022
https://www.sciencedirect.com/journal/epidemics/vol/38/suppl/C

Research article Open access
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland
Andrew J. Shattock, Epke A. Le Rutte, Robert P. Dünner, Swapnoleena Sen, … Melissa A. Penny
Article 100535

Epidemics
Volume 38 March 2022
https://www.sciencedirect.com/journal/epidemics/vol/38/suppl/C

Research article Open access
Challenges in estimation, uncertainty quantification and elicitation for pandemic modelling
Ben Swallow, Paul Birrell, Joshua Blake, Mark Burgman, … Ian Vernon
Article 100547

Epidemics
Volume 38 March 2022
https://www.sciencedirect.com/journal/epidemics/vol/38/suppl/C

Research article Open access
Recalibrating the notion of modelling for policymaking during pandemics
Yot Teerawattananon, Sarin KC, Y.-Ling Chi, Saudamini Dabak, … Suwit Wibulpolprasert
Article 100552

Ethics & Human Research
Volume 44, Issue 2 Pages: 1-40 March–April 2022
https://onlinelibrary.wiley.com/toc/25782363/current

Articles
Evaluating the Ability to Consent to Research: A Twenty-Year Track Record
Mikaela Matera-Vatnick, Katherine W. Todman, Paul G. Wakim, Haley K. Sullivan, Carol Squires, Julie Brintnall-Karabelas, Samuel N. Doernberg, Marion Danis
Pages: 2-17
First Published: 26 February 2022

Ethics & Human Research
Volume 44, Issue 2 Pages: 1-40 March–April 2022
https://onlinelibrary.wiley.com/toc/25782363/current

Consent and decisional capacity; Outside experts and IRBs; Therapeutic misconception

Health Economics, Policy and Law 
Volume 17 – Issue 2 – April 2022
https://www.cambridge.org/core/journals/health-economics-policy-and-law/latest-issue

Article
Alternative provision of public health care: the role of citizens’ satisfaction with public services and the social responsibility of government
Nissim Cohen, Shlomo Mizrahi, Eran Vigoda-Gadot
Published online by Cambridge University Press: 20 July 2020, pp. 121-140

Health Policy and Planning
Volume 37, Issue 3, March 2022
https://academic.oup.com/heapol/issue/37/3

ORIGINAL ARTICLES
Priority setting and equity in COVID-19 pandemic plans: a comparative analysis of 18 African countries
Lydia Kapiriri, Suzanne Kiwanuka, Godfrey Biemba, Claudia Velez, S Donya Razavi …
Health Policy and Planning, Volume 37, Issue 3, March 2022, Pages 297–309, https://doi.org/10.1093/heapol/czab113

Health Policy and Planning
Volume 37, Issue 3, March 2022
https://academic.oup.com/heapol/issue/37/3

REVIEWS
Meanings and mechanisms of One Health partnerships: insights from a critical review of literature on cross-government collaborations
Syed Shahid Abbas, Tim Shorten, Jonathan Rushton
Health Policy and Planning, Volume 37, Issue 3, March 2022, Pages 385–399, https://doi.org/10.1093/heapol/czab134

Health Research Policy and Systems
http://www.health-policy-systems.com/content
[Accessed 12 Mar 2022]

Rapid method through routine data to evaluate real-world vaccine effectiveness against coronavirus disease 2019 (COVID-19) infection: lessons from Thailand
The objective of this article is to draw lessons from the Thai experience in estimating vaccine effectiveness (VE) for coronavirus disease 2019 (COVID-19) based on routine service data. We found that a matched…
Authors: Natthaprang Nittayasoot, Panithee Thammawijaya, Piyanit Tharmaphornpilas, Chalo Sansilapin, Chuleeporn Jiraphongsa and Rapeepong Suphanchaimat
Citation: Health Research Policy and Systems 2022 20:29

Immunity
Mar 08, 2022 Volume 55 Issue 3 p377-574
https://www.cell.com/immunity/current

Perspective
Single-cell immunology: Past, present, and future
Florent Ginhoux, Adam Yalin, Charles Antoine Dutertre, Ido Amit
In this perspective, Ginhoux, Yalin, Dutertre, and Amit outline the past, present, and future applications of single-cell genomics in immunology and discuss how the integration of multiomics at the single-cell level will pave the way for future advances in immunology research and clinical translation.

JAMA
March 8, 2022, Vol 327, No. 10, Pages 897-1003
https://jamanetwork.com/journals/jama/currentissue

Viewpoint
Long-Acting Cabotegravir for HIV PreventionIssues of Access, Cost, and Equity
Joshua M. Sharfstein, MD; Amy Killelea, JD; Derek Dangerfield, PhD
free access
JAMA. 2022;327(10):921-922. doi:10.1001/jama.2022.0420
This Viewpoint discusses the recent FDA approval of cabotegravir, the first injectable medication to help prevent HIV infection, and how its effectiveness may be complicated by the cost and complexity of the US health care system.

JAMA
March 8, 2022, Vol 327, No. 10, Pages 897-1003
https://jamanetwork.com/journals/jama/currentissue

Anti–SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021
Caroline L. Behr, AB; Karen E. Joynt Maddox, MD, MPH; Ellen Meara, PhD; et al.
free access has active quiz
JAMA. 2022;327(10):980-983. doi:10.1001/jama.2022.1243
This study assesses how a limited supply of monoclonal antibody therapy was allocated to patients at highest risk of severe disease among a population of fee-for-service Medicare beneficiaries with a new COVID-19 diagnosis or confirmed exposure between November 2020 and August 2021.

JAMA
March 8, 2022, Vol 327, No. 10, Pages 897-1003
https://jamanetwork.com/journals/jama/currentissue

Anti–SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021
Caroline L. Behr, AB; Karen E. Joynt Maddox, MD, MPH; Ellen Meara, PhD; et al.
free access has active quiz
JAMA. 2022;327(10):980-983. doi:10.1001/jama.2022.1243
This study assesses how a limited supply of monoclonal antibody therapy was allocated to patients at highest risk of severe disease among a population of fee-for-service Medicare beneficiaries with a new COVID-19 diagnosis or confirmed exposure between November 2020 and August 2021.

Viewpoint
Long-Acting Cabotegravir for HIV PreventionIssues of Access, Cost, and Equity
Joshua M. Sharfstein, MD; Amy Killelea, JD; Derek Dangerfield, PhD
free access
JAMA. 2022;327(10):921-922. doi:10.1001/jama.2022.0420
This Viewpoint discusses the recent FDA approval of cabotegravir, the first injectable medication to help prevent HIV infection, and how its effectiveness may be complicated by the cost and complexity of the US health care system.

JAMA
March 8, 2022, Vol 327, No. 10, Pages 897-1003
https://jamanetwork.com/journals/jama/currentissue

Biotech Innovations
First mRNA HIV Vaccine Clinical Trial Launches
Jennifer Abbasi

JAMA Network
COVID-19 Update March 12, 2022

These articles on COVID-19 were published across the JAMA Network in the last week.

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

Editorial
January 19, 2022
Global Representation During a Global Pandemic
Ethwako Mlia-Phiri, MMed1; Samantha Lissauer, BMedSci, MBChB, MRCPCH, PhD2,3; Jill E. Weatherhead, MD, PhD

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

Original Investigation
Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy
Nir Kugelman, MD; Chen Nahshon, MD; Pninit Shaked-Mishan, PhD; et al.
free access has active quiz
JAMA Pediatr. 2022;176(3):290-295. doi:10.1001/jamapediatrics.2021.5683
This cohort study evaluates maternal and neonatal COVID-19 antibody levels at delivery after receipt of a messenger RNA (mRNA) COVID-19 vaccine during the second trimester of pregnancy.

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

JAMA Pediatrics Patient Page
What Parents Should Consider When Enrolling Children in Research
Lindsay A. Thompson, MD, MS; Rebeccah Mercado, MS
free access
JAMA Pediatr. 2022;176(3):332. doi:10.1001/jamapediatrics.2021.6025
This Patient Page describes how parents may find out about different types of research studies that their child may enroll in and defines informed parental consent and assent.

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries
Jean B. Nachega, MD, PhD, MPH; Nadia A. Sam-Agudu, MD; Rhoderick N. Machekano, PhD, MPH; et al.
open access online only has active quiz
JAMA Pediatr. 2022;176(3):e216436. doi:10.1001/jamapediatrics.2021.6436
This cohort study assesses clinical outcomes and associated factors among children and adolescents hospitalized with COVID-19 in 6 sub-Saharan African countriesAMA Pediatrics Patient Page

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

Research Letter
Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US
Tara Tabibi, BA; Justin M. Barnes, MD, MS; Aneri Shah, BS; et al.
JAMA Pediatr. 2022;176(3):313-316. doi:10.1001/jamapediatrics.2021.4807
This cohort study examines the association of human papillomvirus vaccination with cervical cancer incidence and mortality rates in the US, comparing age groups understood to have differing levels of vaccination.

The Lancet
Mar 12, 2022 Volume 399 Number 10329 p1023-1092, e12-e14
https://www.thelancet.com/journals/lancet/issue/current

Editorial
Ukraine’s humanitarian disaster: priorities for health
The Lancet

Original Articles
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina D.-Y. Lin and Others

New England Journal of Medicine
March 10, 2022 Vol. 386 No. 10
https://www.nejm.org/toc/nejm/medical-journal

Original Articles
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina D.-Y. Lin and Others

New England Journal of Medicine
March 10, 2022 Vol. 386 No. 10
https://www.nejm.org/toc/nejm/medical-journal

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming R.S.G. Sablerolles and Others

New England Journal of Medicine
March 10, 2022 Vol. 386 No. 10
https://www.nejm.org/toc/nejm/medical-journal

Editorials
Audio Interview: Making Covid-19 Vaccines Available around the World E.J. Rubin, L.R. Baden, D.J. Hunter, and S. Morrissey

njp Vaccines
https://www.nature.com/npjvaccines/
[Accessed 12 Mar 2022]

Brief Communication
08 Mar 2022
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
Kevin K. Ariën, Leo Heyndrickx, Isabelle Desombere

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 12 Mar 2022)

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
Elizabeth F. Peacocke, Sonja L. Myhre, Hakan Safaralilo Foss, Unni Gopinathan
Research Article | published 11 Mar 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003944

PLoS One
http://www.plosone.org/
[Accessed 12 Mar 2022]

Research Article
Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France
Antoine Eliès, Claire Bonneau, Sophie Houzard, Roman Rouzier, Delphine Héquet
Research Article | published 11 Mar 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0264821

PLoS One
http://www.plosone.org/
[Accessed 12 Mar 2022]

Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: A cross-sectional survey
Tadesse Tolossa, Bizuneh Wakuma, Ebisa Turi, Diriba Mulisa, Diriba Ayala, Getahun Fetensa, Belayneh Mengist, Gebeyehu Abera, Emiru Merdassa Atomssa, Dejene Seyoum, Tesfaye Shibiru, Ayantu Getahun
Research Article | published 09 Mar 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0265061

PLoS One
http://www.plosone.org/
[Accessed 12 Mar 2022]

Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons
David Ortiz-Paredes, Olivia Varsaneux, James Worthington, Hyejin Park, Shannon E. MacDonald, Nicole E. Basta, Bertrand Lebouché, Joseph Cox, Shainoor J. Ismail, Nadine Kronfli
Research Article | published 09 Mar 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0264145

PNAS – Proceedings of the National Academy of Sciences of the United States
February 15, 2022 | vol. 119 | no. 7
https://www.pnas.org/toc/pnas/119/7

Research Article February 1, 2022 Open Access
Real-time pandemic surveillance using hospital admissions and mobility data
Forecasting the burden of COVID-19 has been impeded by limitations in data, with case reporting biased by testing practices, death counts lagging far behind infections, and hospital census reflecting time-varying patient access, admission criteria, and …
Spencer J. Fox, Michael Lachmann,[…] Lauren Ancel Meyers

Preventive Medicine
Volume 156 March 2022
https://www.sciencedirect.com/journal/preventive-medicine/vol/156/suppl/C

Discussion Full text access
HPV prevention and control – The way forward
Alex Vorsters, F. Xavier Bosch, Mario Poljak, Dur-e-Nayab Waheed, … Suzanne M. Garland
Article 106960

Preventive Medicine
Volume 156 March 2022
https://www.sciencedirect.com/journal/preventive-medicine/vol/156/suppl/C

Regular Articles
Research article Full text access
Intention to vaccinate children for COVID-19: A segmentation analysis among Medicaid parents in Florida
Matthew W. Kreuter, Rachel Garg, Alexis Marsh, Tess Thompson, … Amy McQueen
Article 106959

Public Health
Volume 204 Pages 1-86 (March 2022)
https://www.sciencedirect.com/journal/public-health/vol/204/suppl/C

Research article Abstract only
Factors associated with incomplete child immunization in Pakistan: findings from Demographic and Health Survey 2017-18
A. Ali, A. Zar, A. Wadood
Pages 43-48

Risk Management and Healthcare Policy
https://www.dovepress.com/risk-management-and-healthcare-policy-archive56
[Accessed 12 Mar 2022]

Original Research
Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S): Evidence of Measurement Invariance Across Five Countries
Chen IH, Wu PL, Yen CF, Ullah I, Shoib S, Zahid SU, Bashir A, Iqbal N, Addo FM, Adjaottor ES, Amankwaah GB, Ahorsu DK, Griffiths MD, Lin CY, Pakpour AH
Published Date: 10 March 2022

Science
Volume 375| Issue 6585| 11 Mar 2022
https://www.science.org/toc/science/current

Special issue: COVID-19: 2 years on
Introduction to Special Issue
A time to reflect
BY Caroline Ash. Et al.
10 Mar 2022: 1098-1099
Free

Science
Volume 375| Issue 6585| 11 Mar 2022
https://www.science.org/toc/science/current

Editorial
“Back to normal” is not enough
BY Christina Pagel
10 Mar 2022: 1069-1069

Science
Volume 375| Issue 6585| 11 Mar 2022
https://www.science.org/toc/science/current

Policy Forum
End COVID-19 in low- and middle-income countries
BY Ahmed Mushfiq Mobarak et al.
10 Mar 2022: 1105-1110
Free

Science
Volume 375| Issue 6585| 11 Mar 2022
https://www.science.org/toc/science/current

Gender-responsive social protection post–COVID-19
BY Maja Gavrilovic, et al.
10 Mar 2022: 1111-1113
Free
Investment in gender-responsive social protection systems and evidence is key to a more equal future post–COVID-19

Science
Volume 375| Issue 6585| 11 Mar 2022
https://www.science.org/toc/science/current

Reviews
COVID-19 vaccination: The road ahead
BY Daniel M. Altmann, Rosemary J. Boyton
10 Mar 2022: 1127-11
A diverse array of successful, first-generation SARS-CoV-2 vaccines have played a huge role in efforts to bring the COVID-19 pandemic under control, even though inequitable distribution still leaves many vulnerable. Additional challenges loom for the next …

Science
Volume 375| Issue 6585| 11 Mar 2022
https://www.science.org/toc/science/current

Reports
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
BY Ottavia Prunas. Et al.
27 Jan 2022: 1151-1154
Open Access
Vaccination reduced both the rate of infection with SARS-CoV-2 and household transmission in Israel.

Science
Volume 375| Issue 6585| 11 Mar 2022
https://www.science.org/toc/science/current

Indirect protection of children from SARS-CoV-2 infection through parental vaccination
BY Samah Hayek et al.
27 Jan 2022: 1155-1159
Open Access
Parental Covid-19 vaccination confers substantial protection for unvaccinated children in the household.

Tropical Medicine & International Health
Volume 27, Issue 3 Pages: i-iv, 217-336 March 2022
https://onlinelibrary.wiley.com/toc/13653156/current

RESEARCH ARTICLES
Impact of meningococcal C conjugate vaccine on incidence of invasive meningococcal disease in an 18-year time series in Brazil and in distinct Brazilian regions
Mariana C. Cruz, Paulo Camargos, Cristiana M. Nascimento-Carvalho
Pages: 280-289
First Published: 08 January 2022

Vaccine
Volume 40, Issue 8 Pages 1061-1190 (16 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/8

Research article Full text access
Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines
Qiuyan Liao, Benjamin J. Cowling, Jingyi Xiao, Jiehu Yuan, … Wendy Wing Tak Lam
Pages 1074-1081

Vaccine
Volume 40, Issue 8 Pages 1061-1190 (16 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/8

Research article Open access
‘I trust them because my mum trusts them’: Exploring the role of trust in HPV vaccination decision-making among adolescent girls and their mothers in France
E. Karafillakis, P. Peretti-Watel, P. Verger, T. Chantler, H.J. Larson
Pages 1090-1097

Vaccine
Volume 40, Issue 8 Pages 1061-1190 (16 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/8

Research article Abstract only
Factors associated with maternal tetanus vaccination in Myanmar: An analysis of demographic and health survey data
Zaw Myo Tun, Zau Ring, Clarence C. Tam
Pages 1135-1142